An event organised in the framework of the French Presidency of the Council of the European Union (1).<br /><br />The Real World Evidence Conference, organized by the ANSM was held on March 8 and 9.<br /><br />The use of real-world data is a rapidly expanding area in healthcare product development and monitoring due to increased capabilities for massive data collection based on improved computing and digital capabilities. <br />The recent pandemic has significantly accelerated data sharing, but the impact is much broader...<br /><br />The Real World Data conference was an opportunity to give voice to European experts, share experiences from different countries and discuss in a roundtable.<br /><br />(1) This event is not organized by the French Government but is authorized to use the French Presidency of the Council of the European Union logo.<br /><br /><br /><br />▬▬▬▬▬▬▬▬▬▬▬ SOMMAIRE DE LA VIDEO ▬▬▬▬▬▬▬▬▬▬▬<br /><br />00:00 Générique<br />00:00:16 Introduction Christelle Ratignier Carbonneil, Director general, ANSM, France<br />00:07:56 Reinforced pharmacovigilance of COVID-19 vaccines surveillance in France<br />00:28:02 The French Regional Pharmacovigilance Network in COVID-19 Vaccines safety monitoring<br />00:51:00 Questions & Answer<br />00:56:45 An European pharmacovigilance system in the COVID-19 vaccines surveillance –the Norwegian experience<br />01:20:28 Questions & Answer<br />01:28:56 Pharmaco-epidemiology studies<br />02:16:36 Questions & Answer<br />02:18:51 Information and transparency<br />02:24:15 Real World Data in the European decision<br />02:39:24 Questions & Answer<br />02:43:35 Conclusion session 1<br />02:48:00 Introduction session 2<br />02:51:01 Academia-regulator collaboration in covid-19<br />03:25:55 Questions & Answer<br />03:37:31 An Italian Distributed Multi‑Database Healthcare Network:The VALORE Project<br />04:10:19 Questions & Answer<br />04:28:20 Generating evidence using an international common data model<br />04:52:17 Questions & Answer<br />05:04:04 Enhancing use of real-world evidence for regulatory purposes: DARWIN EU® and the EMA registry initiative<br />05:36:32 Questions & Answer<br />05:43:42 Conclusion session 2<br /><br /><br />#ANSM #BigData #PFUE
